Action comes after FDA panel also approved the booster for those groupsEight Democrats and one Republican oppose bill, and two Democrats vote ‘present’Democrats reach agreement on framework to pay for reconciliation billHouse panel holds hearing on ‘surge in air rage’Sign up to receive First Thing – our daily briefing by email 11.49pm BST Abdullah Shihipar reports: Alexandra was working in the public health emergencies unit in a major north-eastern American city when the first wave of the pandemic hit. Although her job was in public health policy research, and not treating Coovid-19 patients on the frontlines of the healthcare system, she recalls the spring of 2020 as a blur of 24-hour shifts. Related: US public health workers leaving ‘in droves’ amid pandemic burnout 11.35pm BST A panel at the Centers for Disease Control and Prevention (CDC) has approved Pfizer-BioNTech booster shots for high-risk people and seniors. Yesterday, an FDA panel also approved the booster for those two groups, and for frontline workers in healthcare, education, and essential businesses – but the CDC panel voted down the latter recommendation. Related: CDC experts advise Covid booster shots for over-65s and vulnerable Americans Continue reading…
Read More
